Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Paeonol inhibits the Glycolysis in oral squamous cell carcinoma though suppressing NAT10-mediated ac4C modification

Fig. 3

Paeonol treatment regulated NAT10-mediated ac4C modification in OSCC. A, Dot blot assay was performed to assess the ac4C level in each group (n = 3); B, RT-qPCR was performed to analyze the mRNA level of NAT10 in the control and paeonol groups (n = 3); C-E, Molecular docking of NAT10 and paeonol; F, The binding sensorgram (for the interactions between paeonol and NAT10). (***p < 0.001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us